(Q33749227)

English

Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease (English)

1 reference

Europe PubMed Central

29 July 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Manns BJ

1

1 reference

Europe PubMed Central

29 July 2017

Burgess ED

2

1 reference

Europe PubMed Central

29 July 2017

Hyndman ME

3

1 reference

Europe PubMed Central

29 July 2017

Parsons HG

4

1 reference

Europe PubMed Central

29 July 2017

Schaefer JP

5

1 reference

Europe PubMed Central

29 July 2017

Scott-Douglas NW

6

1 reference

Europe PubMed Central

29 July 2017

publication date

1 October 1999

1 reference

Europe PubMed Central

29 July 2017

American Journal of Kidney Diseases

1 reference

Europe PubMed Central

29 July 2017

34

1 reference

Europe PubMed Central

29 July 2017

4

1 reference

Europe PubMed Central

29 July 2017

669-677

1 reference

Europe PubMed Central

29 July 2017

Putative atherogenic factors in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperhomocysteinemia as a risk factor for cardiovascular disease in patients undergoing hemodialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of blood sample aging and food consumption on plasma total homocysteine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970392-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0272-6386(99)70392-6

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33749227&oldid=1963134233"